CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2021		21,668,644
Beginning balance at Dec. 31, 2021	$ 676,172	$ 21,669	$ 459,228	$ 206,228	$ 7,978	$ (18,931)
Treasury stock, beginning balance (in shares) at Dec. 31, 2021						(649,607)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	62,919			62,919
Common stock repurchased (in shares)						(600,000)
Common stock repurchased	(22,180)					$ (22,180)
Other comprehensive income (loss)	(156,935)				(156,935)
Dividend on common stock	(16,524)			(16,524)
Issuance of common shares acquisition (in shares)		3,498,936
Issuance of common shares acquisition	101,469	$ 3,499	97,970
Issuance restricted stock grant (in shares)		129,950
Issuance restricted stock grant	0	$ 130	(130)
Restricted stock grant forfeited (in shares)		(2,500)
Restricted stock grant forfeited	0	$ (3)	3
Compensation expense	2,425		2,425
Repurchase of restricted stock for payment of taxes (in shares)		(19,661)
Repurchase of restricted stock for payment of taxes	(683)	$ (20)	(663)
Ending balance (in shares) at Dec. 31, 2022		25,275,369
Ending balance at Dec. 31, 2022	$ 646,663	$ 25,275	558,833	252,623	(148,957)	$ (41,111)
Treasury stock, ending balance (in shares) at Dec. 31, 2022	(1,249,607)					(1,249,607)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 75,457			75,457
Other comprehensive income (loss)	31,381				31,381
Dividend on common stock	(27,930)			(27,930)
Issuance of common shares acquisition (in shares)		6,920,422
Issuance of common shares acquisition	221,522	$ 6,920	214,602
Issuance restricted stock grant (in shares)		167,173
Issuance restricted stock grant	0	$ 167	(167)
Restricted stock grant forfeited (in shares)		(12,194)
Restricted stock grant forfeited	0	$ (12)	12
Compensation expense	2,302		2,302
Repurchase of restricted stock for payment of taxes (in shares)		(11,787)
Repurchase of restricted stock for payment of taxes	(361)	$ (11)	(350)
Ending balance (in shares) at Dec. 31, 2023		32,338,983
Ending balance at Dec. 31, 2023	$ 949,034	$ 32,339	775,232	300,150	(117,576)	$ (41,111)
Treasury stock, ending balance (in shares) at Dec. 31, 2023	(1,249,607)					(1,249,607)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 77,194			77,194
Other comprehensive income (loss)	8,018				8,018
Dividend on common stock	(31,162)			(31,162)
Issuance restricted stock grant (in shares)		164,844
Issuance restricted stock grant	0	$ 165	(165)
Restricted stock grant forfeited (in shares)		(26,561)
Restricted stock grant forfeited	0	$ (27)	27
Compensation expense	4,622		4,622
Repurchase of restricted stock for payment of taxes (in shares)		(67,304)
Repurchase of restricted stock for payment of taxes	(2,275)	$ (67)	(2,208)
Ending balance (in shares) at Dec. 31, 2024		32,409,962
Ending balance at Dec. 31, 2024	$ 1,005,431	$ 32,410	$ 777,508	$ 346,182	$ (109,558)	$ (41,111)
Treasury stock, ending balance (in shares) at Dec. 31, 2024	(1,249,607)					(1,249,607)